Skip to content
herobanner

Strength in Times of Adversity: New Brand Identity Reflects Solidarity with Clients, Team & Community

Dear Avomeen Client,

Avomeen is better positioned than ever before to partner with our clients during the fight against COVID-19. Over the past few years, we have strengthened our service offerings and deepened our scientific expertise, and as a result, we are positioned to partner on new and emerging biologic therapies, vaccines and COVID-19 serology testing, in addition to small batch manufacturing of large-molecule compounds. Our innovation and formulation experts, as well as analytical and CMC scientists, are also being called upon to support projects that mitigate COVID-19 viral spread.

During this difficult time, we are doing all that we can to support our team, clients, and the communities in which we serve. Yet we also are proud to launch a new brand and identity for the first time since Avomeen was founded in 2010. While this launch was initially planned for March, we elected to hold-off in light of the pandemic. As the number of opportunities for Avomeen to help in this pandemic continues to increase each day, we have elected to proceed as our new brand and identity better reflects the many more services and capabilities we can bring in support of the fight.

Our new, modernized brand reflects our evolution as an analytical contract research organization (CRO) to a multi-industry contract development and manufacturing organization (CDMO) and our commitment to collaboration, innovation, and scientific expertise. The new logo and brand elements will be incorporated into the Avomeen website, contracts, and documents. Contact information including phone numbers, email addresses, location, and web address remain the same.

During this global pandemic, our commitment to working alongside our clients and communities is embodied in each and every one of our team members. As we are all are called to dig deep to find our courage and patriotism during this crisis, we stand with our clients as they embrace and adapt to the scientific challenges today and in the coming months. As we keep pressing forward in this fight together, our team is ready to think big and partner with you now and in the days to come.

With our wishes for your good health and safety,

 

Mark Harvill
CEO